Background And Objective: Knowledge of the C-reactive protein trend and deviation from the expected value may give an early indication of a possible postoperative infection. According to previous studies, CRP appears to be a more sensitive and specific marker of postoperative infections than ESR and white cell count. This study was conducted to determine the diagnostic accuracy of C-reactive protein to rule out surgical site infection in patients undergoing hip fracture surgery.
Methods: This cross-sectional study was conducted at The Indus Hospital and Health Network, Karachi from July 1, 2018 to February 24, 2020. All operative hip fracture patients aged 11-90 years were included. CRP was done on admission, days 3, 14 and 28. Wound assessment was done using the criteria of the Center of Disease Control and prevention on postoperative days 3, 14 and 28. Data was analyzed using STATA version 16.
Results: Out of 152 patients, 11(7.2%) developed infection. One patient (0.7%) presented with the infection on day three post-surgery, eight (5.3%) and two (1.3%) patients on days 14 and 28 respectively. CRP levels at admission had poor diagnostic accuracy for diagnosing infection at 14 and 28 day post-surgery respectively (AUC=0.490 and 0.447). CRP levels measured on post-op Day-3 (cutoff value 230mg/dl) had good diagnostic accuracy for diagnosing infection at 14 and 28 day post-surgery respectively (AUC=0.819 and 0.818).
Conclusion: CRP level at post-operative day three is a sensitive indicator of infection after hip fracture surgery.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378397 | PMC |
http://dx.doi.org/10.12669/pjms.38.6.5577 | DOI Listing |
Int J Surg
January 2025
Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Background: Adopting appropriate noninvasive radiological method is crucial for periodic surveillance of liver metastases in colorectal cancer (CRC) patients after surgery, which is closely related to clinical management and prognosis. This study aimed to prospectively enroll stage II-III CRC patients for the surveillance of liver metastases, and compare the diagnostic performance of contrast-enhanced CT (CE-CT) and non-enhanced abbreviated MRI (NE-AMRI) during this process.
Methods: 587 CRC patients undergoing radical resection of the primary tumor were evaluated by 1 to 3 rounds of surveillance tests, consisting of abdominal CE-CT and contrast-enhanced MRI (CE-MRI) within 7 days at 6-month intervals.
Scand J Gastroenterol
January 2025
Department of Internal Medicine, Section of Gastroenterology, Esbjerg Hospital - University Hospital of Southern Denmark, Esbjerg, Denmark.
Background And Aims: Prior studies indicate that serum calprotectin (SC) and plasma calprotectin (PC) can be used as biomarkers in Crohn's disease (CD). The aim of this study was to investigate the diagnostic accuracy of SC and PC in patients with a clinical suspicion of CD.
Method: This biobank study included patients from a prospective, blinded, multicenter study examining minimally invasive modalities for diagnosing CD.
Int J Nurs Knowl
January 2025
Paulista Nursing School, Federal University of São Paulo, São Paulo, São Paulo, Brasil.
Purpose: To determine the accuracy of nursing diagnoses at hospital admission and discharge for patients with heart failure (HF).
Methods: This comparative study examined the documentation in 155 medical records of patients with an admitting diagnosis of HF during August 2018 and July 2019. An audit tool was used to record the diagnoses made by nurses during routine care at the time of admission and discharge.
Alzheimers Dement
January 2025
Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.
Introduction: Plasma phosphorylated tau (p-tau) biomarkers have improved Alzheimer's disease (AD) diagnosis, but data from diverse Asian populations are limited. This study evaluated plasma p-tau217 and p-tau181 levels in Korean and Taiwanese populations.
Methods: All participants (n = 270) underwent amyloid positron emission tomography (PET) and blood tests.
Gastro Hep Adv
October 2024
Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, California.
Background And Aims: Patient-reported outcomes (PROs) are vital in assessing disease activity and treatment outcomes in inflammatory bowel disease (IBD). However, manual extraction of these PROs from the free-text of clinical notes is burdensome. We aimed to improve data curation from free-text information in the electronic health record, making it more available for research and quality improvement.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!